Suven Pharmaceuticals Revenue

Suven Pharmaceuticals had revenue of 2.58B INR in the quarter ending September 30, 2024, with 11.54% growth. This brings the company's revenue in the last twelve months to 9.61B, down -26.16% year-over-year. In the fiscal year ending March 31, 2024, Suven Pharmaceuticals had annual revenue of 10.51B, down -21.56%.

Revenue (ttm)

9.61B

Revenue Growth

-26.16%

P/S Ratio

29.56

Revenue / Employee

8.06M

Employees

1,193

Market Cap

284.26B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%
Mar 31, 2021	10.10B	1.76B	21.10%
Mar 31, 2020	8.34B	-730.13M	-8.05%
Mar 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Suven Pharmaceuticals News

4 days ago - Suven Pharmaceuticals acquires 56% stake in NJ Bio for Rs 533 crore - Business Upturn
17 days ago - Suven Pharma acquires 56% stake in US-based NJ Bio - The Times of India
18 days ago - Suven Pharmaceuticals acquires 56% stake in NJ Bio for Rs 534.52 crore - Business Upturn
3 months ago - Suven Pharma shares surge 3% after appointment of Vivek Sharma as Executive Chairman - Business Upturn

More News